Cardiovascular Care for the Survivor of Hodgkin Lymphoma | Journal Scan

Study Questions:

Compared with cardiovascular disease incidence in the general population, what are the relative and absolute excess cardiovascular risks up to 40 years after treatment of Hodgkin Lymphoma (HL)?